Document:

EXHIBIT 10.1

                            FORM OF CONVERTIBLE NOTE

THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER
THE SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT") OR APPLICABLE
STATE SECURITIES LAWS, AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT
PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT FOR SUCH SECURITIES UNDER THE
SECURITIES ACT AND APPLICABLE STATE SECURITIES LAWS OR PURSUANT TO AN OPINION OF
COUNSEL REASONABLY SATISFACTORY TO THE COMPANY THAT THERE IS AN AVAILABLE
EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT.

Subscription Amount: [amount]                                 Irvine, California
                                                       Subscription Date: [date]

      FOR VALUE RECEIVED, NUWAY MEDICAL, INC., a corporation organized under the
laws of the state of Delaware ("Borrower"), promises to pay to the order of
"Investor", as that term is defined below (hereafter, together with any
subsequent holder hereof, called "Holder"), at its office at "Investor's
Address", as that term is defined below, or at such other place as Holder may
direct, the "Subscription Amount", noted above (the "Loan"), payable in full one
year from the "Subscription Date", or at an earlier date as provided herein (the
"Maturity Date"). This Convertible Term Note is duly authorized issue of the
Borrower (the "Issuer"), issued on the Subscription Date (the "Issuance Date"),
and designated as its Convertible Term Note due one year from the Issuance Date
(the "Note").

      The Borrower agrees to pay interest on the unpaid principal amount of the
Term Loan from time to time outstanding hereunder at the following rates per
year, compounded annually: (i) before maturity of the Loan, whether by
acceleration or otherwise, at the rate per annum equal to ten percent (10%);
(ii) after the maturity of the Loan, whether by acceleration or otherwise, until
paid, at a rate per annum equal to fifteen percent (15%).

         Payments of both principal and interest are to be made in immediately
available funds in lawful money of the United States of America, or in Common
Stock of the Borrower as set forth below.

         Accrual of interest shall commence as of the Issuance Date. Interest
shall be payable by the Issuer, at the Issuer's option, in cash or in that
number of shares of Common stock of the Issuer (the "Common Stock") (at a price
per share calculated pursuant to the conversion formula contained below), upon
the earlier to occur of (i) upon conversion of this Note pursuant to the
conversion features set forth below, or (ii) upon an Event of Default as defined
below, and if an Event of Default occurs interest due hereunder shall be payable
in cash or stock as set forth herein at the option of the Holder. Unless
otherwise agreed in writing by both parties hereto, the interest so payable will

                                       4
<PAGE>

be paid to the person in whose name this Note (or one or more predecessor Notes)
is registered on the records of the Issuer regarding registration and transfers
of the Note (the "Note Register"), provided, however, that the Issuer's
obligation to a transferee of this Note arises only if such transfer, sale or
other disposition is made in accordance with the terms and conditions contained
in the Agreement and this Note.

     The Note is subject to the following additional provisions:

1. The Issuer shall be entitled to withhold from all payments of principal
and/or interest of this Note any amounts required to be withheld under the
applicable provisions of the U.S. Internal Revenue Code of 1986, as amended, or
other applicable laws at the time of such payments.

2. This Note has been issued subject to investment representations of the
original Holder hereof and may be transferred or exchanged only in compliance
with the Securities Act and applicable state securities laws and in compliance
with the restrictions on transfer provided in the Agreement. Prior to the due
presentment for such transfer of this Note, the Issuer and any agent of the
Issuer may treat the person in whose name this Note is duly registered on the
Issuer's Note register as the owner hereof for the purpose of receiving payment
as herein provided and all other purposes, whether or not this Note is overdue,
and neither the Issuer nor any such agent shall be affected by notice to the
contrary. The transferee shall be bound, as the original Holder by the same
representations and terms described herein and under the Agreement.

3. The Holder or Issuer may, at its option, at any time convert the principal
amount of this Note or any portion thereof, and any accrued interest thereon,
into a number shares of fully paid and non assessable Common Stock of the Issuer
pursuant to the following formula: the Subscription Amount divided by [price]
("Conversion Shares"). The right to convert the Note may be exercised by
telecopying an executed and completed notice of conversion (the "Notice of
Conversion") to the Holder or Issuer. Each business day on which a Notice of
Conversion is telecopied in accordance with the provisions hereof shall be
deemed a "Conversion Date". The Issuer will transmit the certificates
representing Conversion Shares issuable upon such conversion of the Note
(together with the certificates representing the Note not so converted) to the
Holder via express courier, by electronic transfer (if applicable) or otherwise
within ten Business Days after the Conversion Date, provided, the Issuer has
received the original Note being so converted from the Holder. If the Company
has not received the original Note being converted within three Business Days
after Conversion Date, then the Issuer shall transmit the certificates
representing the Conversion Shares issuable upon such conversion of the Note
(together with the certificates representing the Note not so converted) to the
Holder via express courier, by electronic transfer (if applicable) or otherwise
within five business days after receipt of the original Notice of Conversion and

                                       5
<PAGE>

original Note being converted. The Conversion of this note may require that the
Issuer amend its charter to increase the number of common shares authorized and
therefore, the conversion may not take place prior to the Issuer's completion of
that process. Any delay due to such circumstance shall not be an event of
default under this Note. Issuer shall promptly take action to affect such
amendments to its charter.

4. The principal amount of this Note, and any accrued interest thereon, shall be
reduced as per that principal amount indicated on the Notice of Conversion upon
the proper receipt by the Holder of such Conversion Shares due upon such Notice
of Conversion.

5. The number of Conversion Shares shall be adjusted as follows:

a. If the Issuer shall at any time subdivide its outstanding shares of Common
Stock into a greater number of shares of Common Stock, the number of Conversion
Shares in effect immediately prior to such subdivision shall be proportionately
increased, and conversely, in case the outstanding shares of Common Stock shall
be combined into a smaller number of shares of Common Stock, the Conversion
Price in effect immediately prior to such combination shall be proportionately
reduced.

6. No provision of this Note shall alter or impair the obligation of the Issuer,
which is absolute and unconditional, upon an Event of Default (as defined
below), to pay the principal of, and interest on this Note at the place, time,
and rate, and in the coin or currency herein prescribed.

7. Events Of Default. Each of the following occurrences is hereby defined as an
"Event of Default":

                       Nonpayment. The Borrower shall fail to make any payment
                       of principal, interest, or other amounts payable
                       hereunder when and as due; or

                       Dissolutions, etc. The Borrower or any subsidiary shall
                       fail to comply with any provision concerning its
                       existence or any prohibition against dissolution,
                       liquidation, merger, consolidation or sale of assets; or

                       Litigation. Any suit, action or other proceeding
                       (judicial or administrative) commenced against the
                       Borrower or any of its subsidiaries, or with respect to
                       any assets of the Borrower or such subsidiary, shall
                       threaten to have a material and adverse effect on the
                       asset, condition (financial or otherwise) or future
                       operations of the Borrower or such subsidiary; or a final
                       judgment or settlement in excess of $100,000 in excess of
                       insurance shall be entered in, or agreed to in respect
                       of, any such suit, action or proceeding; or

                       Noncompliance with this Agreement. The Borrower shall
                       fail to comply in any material respect with any provision
                       hereof, which failure does not otherwise constitute an
                       Event of Default, and such failure shall continue for ten
                       (10) days after the occurrence of such failure; or

                                       6
<PAGE>

                       Bankruptcy. Any bankruptcy, insolvency, reorganization,
                       arrangement, readjustment, liquidation, dissolution, or
                       similar proceeding, domestic or foreign, is instituted by
                       or against the Borrower or any of its subsidiaries, or
                       the Borrower or any of its subsidiaries shall take any
                       step toward, or to authorize, such a proceeding; or

                       Insolvency. The Borrower becomes insolvent, generally
                       shall fail or be unable to pay its debts as they mature,
                       shall admit in writing its inability to pay its debts as
                       they mature, shall make a general assignment for the
                       benefit of its creditors, shall enter into any
                       composition or similar agreement, or shall suspend the
                       transaction of all or a substantial portion of its usual
                       business.

                       If one or more "Events of Default" shall occur, then, or
at any time thereafter, and in each and
every such case, unless such Event of Default shall have been waived in writing
by the Holder (which waiver shall not be deemed to be a waiver of any subsequent
default) or cured as provided herein, at the option of the Holder, and in the
Holder's sole discretion, the Holder may elect to consider this Note (and all
interest through such date) immediately due and payable. In order to so elect,
the Holder must deliver written notice of the election and the amount due to the
Borrower via certified mail, return receipt requested, at the Borrower's address
as set forth herein (or any other address provided to the Holder), and
thereafter the Borrower shall have ten business days upon receipt to cure the
Event of Default, pay the Note, or convert the amount due on the Note pursuant
to the conversion formula set forth above. It is agreed that in the event of
such action, such Holder shall be entitled to receive all reasonable fees, costs
and expenses incurred, including without limitation such reasonable fees and
expenses of attorneys. The parties acknowledge that a change in control of the
Issuer shall not be deemed to be an Event of Default as set forth herein.

      8. In case any provision of this Note is held by a court of competent
jurisdiction to be excessive in scope or otherwise invalid or unenforceable,
such provision shall be adjusted rather than voided, if possible, so that it is
enforceable to the maximum extent possible, and the validity and enforceability
of the remaining provisions of this Note will not in any way be affected or
impaired thereby.

      9. The Holder shall have the right, if applicable, to include all of the
Conversion Shares underlying this Note (the "Registrable Securities") as part of
any registration of securities filed by the Issuer (other than in connection
with a transaction contemplated by Rule 145(a) promulgated under the Act or
pursuant to Form S-4 or S-8) and must be notified in writing of such filing as
soon as reasonably practicable; PROVIDED, HOWEVER, that the Holder agrees it
shall not have any piggy-back registration rights pursuant to this Note if the
Conversion Shares underlying this Note may be sold in the United States pursuant
to the provisions of Rule 144 without any restriction on resale. Holder shall
have five business days after receipt of the aforementioned notice from the
Issuer, to notify the Issuer in writing as to whether the Issuer is to include
Holder or not include Holder as part of such registration; PROVIDED, HOWEVER,

                                       7
<PAGE>

that if any registration pursuant to this paragraph shall be underwritten, in
whole or in part, the Issuer may require that the Registrable Securities
requested for inclusion pursuant to this paragraph be included in the
underwriting on the same terms and conditions as the securities otherwise being
sold through the underwriters. If in the good faith judgment of the underwriter
evidenced in writing of such offering only a limited number of Registrable
Securities should be included in such offering, or no such shares should be
included, the Holder, and all other selling stockholders, shall be limited to
registering such proportion of their respective shares as shall equal the
proportion that the number of shares of selling stockholders permitted to be
registered by the underwriter in such offering bears to the total number of all
shares then held by all selling stockholders desiring to participate in such
offering. All registration expenses incurred by the Issuer in complying with the
terms of this Note shall be paid by the Issuer, exclusive of underwriting
discounts, commissions and legal fees and expenses for counsel to the Holder.

                  This Note does not entitle the Holder hereof to any voting
rights or other rights as a shareholder of the Issuer prior to the conversion
into Common Stock thereof, except as provided by applicable law. If, however, at
the time of the surrender of this Note and conversion the Holder hereof shall be
entitled to convert this Note, the Conversion Shares so issued shall be and be
deemed to be issued to such holder as the record owner of such shares as of the
close of business on the Conversion Date.

         IN WITNESS WHEREOF, the Issuer has caused this Convertible Term Note to
be duly executed by an officer thereunto duly authorized.

NUWAY MEDICAL, INC.

By
  ---------------------------------
Name: Dennis Calvert, its President

ACKNOWLEDGED AND ACCEPTED:

         Investor Name: [investor]

         Investor Signature:
                             ------------------------------------------

                                       8[SWISS MEDICA LETTERHEAD]
                                      GET ON WITH IT.

PERSONAL & CONFIDENTIAL

June 24, 2005

Mr. Charlie Orr
476 Oakshire Place
Alamo, CA 94507

Dear Charlie,

On behalf of the Board of Directors of Swiss Medica Inc., we are pleased to
invite you to become a member of our Board.

Both the management and directors of Swiss Medica are very impressed with your
extensive business experience and business network, and feel that you can bring
tremendous value to Swiss Medica.

Our outsider board member package is as follows:

o     150,000 restricted shares of Swiss Medica that will be saleable under Rule
      144A (SEC) in one year's time. This is addition to the 150,000 shares
      previously issued in 2003.

o     Annual cash retainer fee paid monthly commencing July 1, 2005 paying
      US$3,000.00 per month.

In addition, the company will reimburse all reasonable business expenses
incurred on behalf of Swiss Medica.

Charlie, I am personally looking forward to working closely with you and
building a strong viable company for our shareholders.

If this offer is acceptable to you, we are proposing that it become effective
June 29, 2005, and request that you please sign below, returning one copy to us
and retaining one copy for your records.

Sincerely,

SWISS MEDICA INC.

/s/ Bryson Farrill
--------------------------------
Bryson Farrill
Chairman

<PAGE>

June 24, 2005
Mr. Charlie Orr

ACCEPTED THIS 29th day of June, 2005.

/s/ Charlie T. Orr
--------------------------------
Charlie Orr

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00087-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00087-of-00352.parquet"}]]